APA (7th ed.) Citation

Haller, M. J., Gitelman, S. E., Gottlieb, P. A., Michels, A. W., Rosenthal, S. M., Shuster, J. J., . . . Schatz, D. A. (2015). Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. The Journal of clinical investigation, 125(1), 448-455. https://doi.org/10.1172/JCI78492

Chicago Style (17th ed.) Citation

Haller, Michael J., et al. "Anti-thymocyte Globulin/G-CSF Treatment Preserves β Cell Function in Patients with Established Type 1 Diabetes." The Journal of Clinical Investigation 125, no. 1 (2015): 448-455. https://doi.org/10.1172/JCI78492.

MLA (9th ed.) Citation

Haller, Michael J., et al. "Anti-thymocyte Globulin/G-CSF Treatment Preserves β Cell Function in Patients with Established Type 1 Diabetes." The Journal of Clinical Investigation, vol. 125, no. 1, 2015, pp. 448-455, https://doi.org/10.1172/JCI78492.